NCT04108351View on ClinicalTrials.gov

Development and Validation of a Driving Simulator for Evaluating the Residual Effects of Drugs on Driving Performance - Sensitivity Analysis Using Zopiclone As a Positive Control

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 7, 2019

Primary Completion Date

February 11, 2020

Study Completion Date

February 11, 2020

Conditions
Healthy Participants
Interventions
OTHER

Road-tracking test

Driving with simulator program for SDLP measurement

OTHER

Car-following test

Intervention Description: Driving with simulator program for DCV measurement

OTHER

Harsh-braking test

Driving with simulator program for BRT measurement

Trial Locations (2)

Unknown

Taisho Pharmaceutical Co., Ltd selected site, Fukuoka

The medical facility selected by Taisho Pharmaceutical Co., Ltd, Fukuoka

All Listed Sponsors
collaborator

Nagoya University

OTHER

lead

Taisho Pharmaceutical Co., Ltd.

INDUSTRY

NCT04108351 - Development and Validation of a Driving Simulator for Evaluating the Residual Effects of Drugs on Driving Performance - Sensitivity Analysis Using Zopiclone As a Positive Control | Biotech Hunter | Biotech Hunter